NEW YORK (TheStreet) -- Seven companies are set to report their quarterly results after the closing bell today, including Dow component and credit-card giant American Express (AXP), biotech giant Amgen (AMGN), pharmacy-benefit manager Express Scripts (ESRX) and U.S. Steel (X).
Among the seven, the biggest year-to-date gainer is Trinity Industries (TRN), whose stock is up 65%. Trinity makes products for railcars, barges and highway construction.
Also Included in today's pre-earnings profiles is gold miner Newmont Mining (NEM), which is up 11% so far this year.
The biggest loser is Panera Bread (PNRA), whose stock has been sliced by 19%.
Let's take a look at the stock profiles. Two "crunching the numbers" tables follow.
Amgen ($122.65) traded as high as $128.96 on March 21 and as low as $108.20 on April 28. It has been vacillating around its 200-day simple moving average since April 10 with this average now at $117.37.
Analysts expect the company to report earnings per share of $1.99. Amgen has a 12-month trailing price-to-earnings ratio of 16.2 and dividend yield of 2%.
The weekly chart is positive with its five-week modified moving average at $119.99. Semiannual and monthly value levels are $120.57 and $119.07, respectively, with weekly and quarterly risky levels at $124.25 and $139.16, respectively.
American Express ($91.86) set an all-time high at $96.24 on July 1, and is between its 200-day SMA at $88.28 and its 50-day SMA at $93.24.
Analysts expect the company to report earnings of $1.38 per share. It has a 12-month trailing P/E of 17.6 and dividend yield at 1.1%.
The weekly chart is negative with its five-week MMA at $92.89. Semiannual and annual value levels are $83.59 and $61.38, respectively, with semiannual and weekly risky levels at $96.66 and $97.02.
Express Scripts ($65.90) set an all-time high at $79.37 on March 11, and fell to a 2014 intraday low at $64.64 on April 30. The stock gapped below its 200-day SMA at $70.12 on April 30.
Analysts expect the company to report earnings of $1.22 per share. Express Scripts has a 12-month trailing P/E of 15.1, and it does not pay a dividend.
The weekly chart is negative with its five-week MMA at $67.94 and its 200-week SMA at $58.32. A weekly pivot is $65.71 with annual risky levels at $72.01 and $72.45.